Health Care/Hospital
Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
ROCKVILLE, Md. and SUZHOU, China, Jan. 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and o...
Cathay Insurance Vietnam and SAWAD Launch One-Stop "Dual Finance" Programme
HO CHI MINH CITY, Vietnam, Dec. 29, 2023 /PRNewswire/ -- Cathay Insurance Vietnam has partnered with SAWAD to launch a one-stop "Dual Finance" programme which allows customers to apply for the financial support, and at the same time, purchase separate mandatory insurance coverage in a streamlined...
ANAESTHESIOLOGIST HERO, DOCTOR'S QUICK THINKING SAVES CYCLIST'S LIFE DURING LEKAS NIGHT RIDE 2023
Off-duty doctor's decisive action and collaboration with fellow physician-cyclists lead to a successful resuscitation and life-saving measures. SELANGOR, MALAYSIA, Dec. 29, 2023 /PRNewswire/ -- In an extraordinary display of quick thinking and medical expertise, Dr. Shahridan Bin Mohd Fathil, an ...
Positive Results In The Interim Analysis Of The Clinical Trial Of Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines
TAIZHOU, China, Dec. 29, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that the novel adjuvanted recombinant shingles vaccine REC610 independently developed by the Company has recently achieved positive...
Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses through at least 3-weeks-- --Durable efficacy and PK profile expected to support convenient dosing interval of ≥2-weeks, compared to daily or weekly d...
HANSIZHUANG Sets Sail in Indonesia Market
* The 1st China anti-PD-1 monoclonal antibody successfully approved in Southeast Asia - * The 1st overseas approval of HANSIZHUANG, highlighting another major milestone of Henlius' global strategy after HANQUYOU - * Along with KGbio and other partners to develop and launch HANSIZHUANG in ov...
RemeGen's Pioneering RC88 Receives IND Approval from US FDA for Platinum-Resistant Recurrent Ovarian Cancer Treatment
YANTAI, China, Dec. 28, 2023 /PRNewswire/ -- RemeGen Co. Ltd.
Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China
ROCKVILLE, Md. and SUZHOU, China, Dec. 28, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...
Visionary Excellence Recognized: VISTA Eye Specialist Clinches Top Honor at Health and Wellness Brand Awards
PETALING JAYA, Malaysia, Dec. 28, 2023 /PRNewswire/ -- VISTA Eye Specialist ('VISTA'),Malaysia's premier eye care group, proudly announces its recent accolade: the coveted Malaysia Health and Wellness Brand Awards ('Award') in the Health Institutions Category for the 4th time. The Award, organize...
Jung Kwan Jang Launches a Limited-edition Red Ginseng, Marking its 124th Anniversary
SEOUL, South Korea, Dec. 28, 2023 /PRNewswire/ -- On December 1, 2023,
Jung Kwan Jang honors its 124th anniversary with the unveiling of the Red
Ginseng Heritage Edition, a tribute to the company's respect for Korean
cultural heritage.
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA
YANTAI, China, Dec. 27, 2023 /PRNewswire/ -- Boan Biotech today announced that two of its Claudin18.2-targeted investigational drugs have been granted the Orphan Drug Designation (ODD) for the treatment of pancreatic cancer by the U.S. Food and Drug Administration (FDA): one is BA1105, an innovat...
Seegene obtains ISO45001 certification
SEOUL, South Korea, Dec. 27, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced that it has achieved an ISO45001 certification on December 27. The Occupational Health and Safety Management System (ISO ...
AIA Hong Kong "Health & Wellness Survey" Defies Stereotypes: Family Overtakes Money as Key to Happiness, Redefines Health and Happiness
HONG KONG, Dec. 27, 2023 /PRNewswire/ -- Are Hong Kong people happy? AIA Hong Kong, a leading advocate for mental and physical health, unveiled the findings of its inaugural "Health & Wellness Survey#". It interviewed 400 Hong Kong residents and delivered a finding that challenges conventional be...
Rx-360® Announces 2024 Board of Directors
PHILADELPHIA, Dec. 27, 2023 /PRNewswire/ -- Rx-360® is pleased to announce its 2024 Board of Directors. As a non-profit, the Board of Directors is positioned to continue driving the Rx-360® mission of pharmaceutical supply chain security, material quality, and patient safety. This announcement fo...
Innovent and SanegeneBio Enter Strategic Collaboration to Develop siRNA Drug for the Treatment of Hypertension
ROCKVILLE, Md. and SUZHOU, China, Dec. 27, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...
Panlin Capital Announces Second Closing for its Healthcare Venture Capital Fund; Has Raised a Total of RMB 1.5 Billion in the Last Two Years
SHANGHAI, Dec. 26, 2023 /PRNewswire/ -- Recently, Panlin Capital announced that Hangzhou Panlin Xukang Fund, a venture capital fund focusing on innovative biopharmaceuticals, innovative medical device and biotechnology, has completed its second closing. This is the first fund that Panlin Capital ...
Castoma Turmeric Milk - A Breakthrough Step That Brings Happiness To People With Stomach Pain
SEOUL, South Korea, Dec. 26, 2023 /PRNewswire/ -- Castoma, a new breakthrough dairy supplement that can support those suffering from stomach disease, has been launched in Korea. Castoma aims to provide relief and comfort to millions of people who struggle with stomach problems such as gastritis, ...
Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered Drug Development in China
SINGAPORE, Dec. 22, 2023 /PRNewswire/ -- Oncoshot, an innovative health insights exchange platform leveraging AI and federated learning, today announced it has forged a strategic partnership with Zhejiang Ablaze Medicine, a leading service provider of end-to-end clinical trial solutions, to joint...
A Pioneer in Data Analytics Excellence: SIFT Analytics Group Drives Digital Transformations for Over 1,000 Businesses Across Southeast Asia
SINGAPORE, Dec. 19, 2023 /PRNewswire/ -- SIFT Analytics
Davos Communications Awards - BGI Genomics Inclusive Instagram Strategy Wins Gold Recognition
HONG KONG, Dec. 22, 2023 /PRNewswire/ -- BGI Genomics, the world's leading provider of integrated solutions for precision medicine, is pleased to announce winning Instagram Campaign (Gold) recognition at the Davos Communications Awards held onDecember 12, 2023. Organized by the World Communicati...
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07